Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07474857Not ApplicableCompleted

Anti-HLA Antibodies After Bone Regeneration Surgery

Role: collaborator

NCT07324213Not ApplicableCompleted

Healing of Mandibular Third Molar Extraction Sockets Using Platelet Concentrates and Photobiomodulation

Role: collaborator

NCT04811456Unknown

MultiOrgan Inflammatory Syndromes COVID-19 Related Study

Role: collaborator

NCT04243460Not ApplicableCompleted

Influence of Soft Tissue Thickness on the Bone Level Around Implants

Role: collaborator

NCT03471000Not ApplicableCompleted

The Influence of the Crown-implant Ratio on the Crestal Bone Level and Implant Secondary Stability

Role: collaborator

All 5 trials loaded